Cargando…
Impact of COVID-19 in patients with lymphoid malignancies
The first cases of coronavirus disease 2019 (COVID-19) were detected in Wuhan, China, in December 2019. Since this time a concerted global effort of research and observational data gathering has meant that a great deal has been learnt about the impact of COVID-19 in patients with lymphoid malignanci...
Autor principal: | Riches, John Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152455/ https://www.ncbi.nlm.nih.gov/pubmed/34079692 http://dx.doi.org/10.5501/wjv.v10.i3.97 |
Ejemplares similares
-
Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas
por: Uhl, Barbara, et al.
Publicado: (2022) -
The interplay between innate lymphoid cells and microbiota
por: Wang, Rui, et al.
Publicado: (2023) -
Radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma
por: Quéro, Laurent, et al.
Publicado: (2021) -
Innate Lymphoid Cells in Tissue Homeostasis and Disease Pathogenesis
por: Kim, Jihyun, et al.
Publicado: (2021) -
Innate Lymphoid Cells in Graft‐Versus‐Host Disease
por: Konya, V., et al.
Publicado: (2015)